Ardelyx

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines.

CEO

Michael G. Raab

CEOMichael G. Raab

Employees

395

Employees395

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2007

Founded2007

Employees

395

Employees395

ARDX Key Statistics

Market cap

1.22B

Market cap1.22B

Price-Earnings ratio

-21.79

Price-Earnings ratio-21.79

Dividend yield

—

Dividend yield—

Average volume

3.35M

Average volume3.35M

High today

$5.21

High today$5.21

Low today

$5.05

Low today$5.05

Open price

$5.17

Open price$5.17

Volume

2.80M

Volume2.80M

52 Week high

$6.78

52 Week high$6.78

52 Week low

$3.21

52 Week low$3.21

ARDX News

Simply Wall St 3d

Sue Hohenleitner’s CFO Appointment Could Be a Game Changer for Ardelyx

On October 13, 2025, Ardelyx announced that Sue Hohenleitner, an accomplished executive with over 30 years of experience at Johnson & Johnson, was appointed as...

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell

People also own

Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.